{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:32Z","timestamp":1788416012928,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clear cell renal cell carcinoma (ccRCC) exhibits substantial molecular and immune heterogeneity. Mast cells participate in tumor-microenvironment remodeling, but the prognostic relevance of mast cell-associated apoptosis-related transcriptional features remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single-cell RNA sequencing was used to identify mast cells in ccRCC. Genes associated with the annotated mast-cell cluster were intersected with the HALLMARK_APOPTOSIS gene set to develop a mast cell-associated apoptosis score (MCAS) using machine-learning survival algorithms. MCAS was evaluated in TCGA-KIRC and two external cohorts. Associations with clinicopathological features, mutation profiles and model-derived genes were analyzed. YBX3 was functionally characterized using qRT-PCR, western blotting, CCK-8, colony formation, EdU, Transwell migration and flow cytometry assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A TPSAB1\/CPA3-positive mast cell population was identified. The CoxBoost plus random survival forest model showed the best performance for MCAS construction. High MCAS scores predicted poor survival in the training and validation cohorts and were associated with advanced clinicopathological features and tumor mutation burden. SurvSHAP and SurvLIME jointly identified BNIP3, CX3CR1, HMOX1, and YBX3. High YBX3 expression was associated with unfavorable prognosis. Functionally, YBX3 knockdown inhibited proliferation, colony formation, DNA synthesis and migration, and promoted apoptosis with increased BAX and decreased Bcl-2, whereas YBX3 overexpression enhanced proliferative and migratory phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      MCAS is a mast cell-associated apoptosis-related transcriptomic signature for prognostic stratification in ccRCC. The\n                      <jats:italic>in vitro<\/jats:italic>\n                      findings suggest that YBX3 may contribute to malignant phenotypes and apoptosis resistance in ccRCC cells.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1894244","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:22:32Z","timestamp":1788412952000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A mast cell-associated apoptosis-related transcriptomic signature in clear cell renal cell carcinoma and in vitro characterization of YBX3"],"prefix":"10.3389","volume":"17","author":[{"given":"Rijian","family":"Guan","sequence":"first","affiliation":[{"name":"The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital","place":["Quzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wan","sequence":"additional","affiliation":[{"name":"The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital","place":["Quzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyun","family":"Feng","sequence":"additional","affiliation":[{"name":"The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital","place":["Quzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose","year":"2024","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-025-02066-z","article-title":"Advances in renal cancer: diagnosis, treatment, and emerging technologies","volume":"130","author":"Saida","year":"2025","journal-title":"Radiol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","article-title":"Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma","volume":"39","author":"Bi","year":"2021","journal-title":"Cancer Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.3390\/ijms27073064","article-title":"Immune escape in renal cell carcinoma: latest research and treatment strategies","volume":"27","author":"Huang","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5702-5","article-title":"Tumor infiltrating mast cells (TIMs) confers a marked survival advantage in nonmetastatic clear-cell renal cell carcinoma","volume":"24","author":"Fu","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13006","article-title":"Mast cell density in metastatic renal cell carcinoma: association with prognosis and tumour-infiltrating lymphocytes","volume":"93","author":"Yao","year":"2021","journal-title":"Scand J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.05.007","article-title":"Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma","volume":"79","author":"Nakanishi","year":"2018","journal-title":"Hum Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1494025","article-title":"Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC","volume":"15","author":"Song","year":"2024","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.12.040","article-title":"Association of mast cells with microvessel density in renal cell carcinomas","volume":"50","author":"Tuna","year":"2006","journal-title":"Eur Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.442","article-title":"Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K\u2192AKT\u2192GSK3\u03b2\u2192AM signaling","volume":"36","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02314-y","article-title":"Tumor infiltrating mast cells determine oncogenic HIF-2\u03b1-conferred immune evasion in clear cell renal cell carcinoma","volume":"68","author":"Xiong","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103999","article-title":"CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients","volume":"12","author":"Liu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"355.e11","DOI":"10.1016\/j.urolonc.2019.01.025","article-title":"Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment","volume":"37","author":"Tamma","year":"2019","journal-title":"Urol Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.567730","article-title":"A novel nine apoptosis-related genes signature predicting overall survival for kidney renal clear cell carcinoma and its associations with immune infiltration","volume":"8","author":"Wang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10235","article-title":"Mast cell-mediated apoptosis of endothelial cells in vitro: a paracrine mechanism involving TNF-alpha-mediated down-regulation of bcl-2 expression","volume":"195","author":"L\u00e4tti","year":"2003","journal-title":"J Cell Physiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m114.610485","article-title":"Proteinase-activated receptor 2 (PAR2) decreases apoptosis in colonic epithelial cells","volume":"289","author":"Iablokov","year":"2014","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1038\/s41467-021-25618-z","article-title":"Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma","volume":"12","author":"Sun","year":"2021","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0860-1","article-title":"High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade","volume":"26","author":"Yuen","year":"2020","journal-title":"Nat Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-2650","article-title":"The web-based portal SpatialTME integrates histological images with single-cell and spatial transcriptomics to explore the tumor microenvironment","volume":"84","author":"Shi","year":"2024","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10142-023-01145-6","article-title":"Identification of RNA-binding protein YBX3 as an oncogene in clear cell renal cell carcinoma","volume":"23","author":"Wang","year":"2023","journal-title":"Funct Integr Genomics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaa151","article-title":"SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data","volume":"9","author":"Young","year":"2020","journal-title":"GigaScience"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41467-022-30755-0","article-title":"Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data","volume":"13","author":"Dimitrov","year":"2022","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"20266","DOI":"10.1038\/s41598-023-46577-z","article-title":"Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-025-04133-x","article-title":"Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma","volume":"26","author":"Dai","year":"2026","journal-title":"Cancer Cell Int"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1016\/j.celrep.2019.05.039","article-title":"The RNA-binding protein YBX3 controls amino acid levels by regulating SLC mRNA abundance","volume":"27","author":"Cooke","year":"2019","journal-title":"Cell Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1894244\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:22:33Z","timestamp":1788412953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1894244\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2026.1894244"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1894244","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1894244"}}